AZD1236
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
AstraZeneca
Overview
AZD1236 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
AZD1236 clinical trials
Explore related
Medical disclaimer. This page summarizes research about AZD1236 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.